Ind Swift Laboratories Limited - Company Profile

It is a pharma public limited company based in Chandigarh, Chandigarh, India, established in 1995.
1995 Chandigarh, Chandigarh, India Active
Last Updated:
About Ind Swift Laboratories Limited

Ind Swift Laboratories Limited, a active public limited company, was established on 04 January 1995 in Chandigarh, Chandigarh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24232CH1995PLC015553. Registered under ROC Roc Chandigarh. it is listed on BSE: 532305 and NSE: INDSWFTLAB. It has an authorized capital of ₹115.00 Cr and a paid-up capital of ₹81.61 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹1,272.63 Cr and a net worth of ₹922.24 Cr. Its leadership includes Neerja Chathley (Director), Rajinder Kumar Gupta (Director), Rishav Mehta (Whole-Time Director). Past directors included Gopal Munjal, Narinder Pal Singh, Sanjeev Rai Mehta. It holds ₹819.92 Cr open charges and ₹5,103.76 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sco 850, Shivalik Enclave, Nac, Manimajra, Chandigarh, Chandigarh, 160101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24232CH1995PLC015553

  • Registration Number

    015553

  • Incorporation Date

    04 January 1995

  • Authorized Capital

    ₹115.00 Cr

  • Paid-Up Capital

    ₹81.61 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Listed (BSE: 532305, NSE: INDSWFTLAB)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 115.00 Cr
  • Paid Up Capital ₹ 81.61 Cr
  • Company Age 31 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 819.92 Cr
  • Satisfied Charges ₹ 5,103.76 Cr
  • Revenue Growth **** 7.37%
  • Profit Growth **** 885.10%
  • Ebitda **** 12.55%
  • Net Worth 36.56%
  • Total Assets -38.22%
Company report

Ind Swift Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ind Swift Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ind Swift Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Neerja Chathley Director 10 May 2019 Current
Rajinder Kumar Gupta Director 23 Jun 2021 Current
Rishav Mehta Whole-Time Director 23 Mar 2010 Current
Subodh Gupta Director 05 Jul 2025 Current
Sahil Munjal Whole-Time Director 13 Feb 2020 Current
Navrattan Munjal Managing Director 04 Jan 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Apr 2019 Past
Pramod Abcsdd Director 09 Oct 2012 Past
Pramod Abcsdd Director 23 Apr 2019 Past
Pramod Abcsdd Additional Director 09 Aug 2013 Past
Pramod Abcsdd Director 07 Nov 2014 Past
Pramod Abcsdd Director 23 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ind Swift Laboratories.

Ind Swift Laboratories Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.37% increase. The company also saw a substantial improvement in profitability, with a 885.1% increase in profit. The company's net worth Soared by an impressive increase of 36.56%.

Ind Swift Laboratories revenue growth over time
Ind Swift Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
7.37%
*******
*******
*******
*******
Revenue from Operations
*******
6.54%
*******
*******
*******
*******
Total Assets
*******
-38.22%
*******
*******
*******
*******
Profit or Loss
*******
885.10%
*******
*******
*******
*******
Net Worth
*******
36.56%
*******
*******
*******
*******
EBITDA
*******
12.55%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ind Swift Laboratories?

In 2024, Ind Swift Laboratories had a promoter holding of 42.01% and a public holding of 58.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,199,170,060.00

Satisfied Charges

₹51,037,607,385.00

Charges Breakdown by Lending Institutions
  • Others : 816.18 Cr
  • First Blue Home Finance Limited : 2.00 Cr
  • Axis Bank Limited : 1.70 Cr
  • Centurian Bank Ltd. : 0.04 Cr
Latest Charge Details
Date Lender Amount Status
30 Mar 2024 Others ₹815.68 Cr Open
29 Aug 2023 Axis Bank Limited ₹1.70 Cr Open
04 Aug 2023 Others ₹5.00 M Open
30 Jul 2011 First Blue Home Finance Limited ₹2.00 Cr Open
18 Nov 2004 Centurian Bank Ltd. ₹0.40 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ind Swift Laboratories?

Unlock and access historical data on people associated with Ind Swift Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ind Swift Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ind Swift Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ind Swift Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ind Swift Laboratories Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Subodh Gupta was appointed as a Director was appointed as a Director on 05 Jul 2025 & has been associated with this company since 7 months 8 days . was completed.

  • Director Appointment

    The activity Prabhat Khurana was appointed as a Additional Director was appointed as a Additional Director on 05 Jul 2025 & has been associated with this company since 7 months 8 days . was completed.

  • Balance Sheet

    The activity Ind Swift Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was completed.

  • Charges

    Progress on A charge registered on 21 Jun 2019 via Charge ID 100270484 with Idbi Trusteeship Services Limited was fully satisfied on 12 Apr 2024. was documented.

  • Charges

    The activity A charge registered on 05 Sep 2018 via Charge ID 100214960 with Others was fully satisfied on 05 Apr 2024. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Ind Swift Laboratories Limited?

The CIN of Ind Swift Laboratories Limited is L24232CH1995PLC015553.

Where is Ind Swift Laboratories Limited headquartered?

Ind Swift Laboratories Limited is headquartered at Sco 850, Shivalik Enclave, Nac, Manimajra, Chandigarh, Chandigarh, 160101.

When was Ind Swift Laboratories Limited incorporated?

Ind Swift Laboratories Limited was incorporated on 04 January 1995.

Who are the current directors of Ind Swift Laboratories Limited?

The current directors of Ind Swift Laboratories Limited are

What is the primary industry of Ind Swift Laboratories Limited?

The primary industry of Ind Swift Laboratories Limited is Manufacturing.

Is Ind Swift Laboratories Limited a listed company?

Ind Swift Laboratories Limited is listed. It is listed on BSE: 532305 and NSE: INDSWFTLAB.

What is the capital structure of Ind Swift Laboratories Limited?

The authorized capital of Ind Swift Laboratories Limited is ₹115.00 Cr, and the paid-up capital is ₹81.61 Cr.

What is the compliance status of Ind Swift Laboratories Limited?

The compliance status of Ind Swift Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available